J Pharm Pharmacol 62(2):241246
People who should exercise caution when using these medications include those with diabetic retinopathy, pancreatitis, gallbladder disease, kidney issues, and stomach or intestinal disorders, such as gastroparesis and digestion problems
Each component determines when it will participate in one of the recurring BAAs or issue a component- specific BAA
Here, we review the physiology and pharmacology of GLP-1 agonists, their current clinical indications, nuanced perioperative considerations, and areas of research needed to establish the safest use of these agents for our patients
Check with your states Medicaid program to find out if it covers semaglutide
You will read about the dangers of insulin resistance and excess insulin, and how some of the drugs that mainstream medicine uses to treat diabetes increase insulin levels without regard to ambient glucose levels, potentially contributing to problems in the long term